DK0462194T3 - Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger - Google Patents

Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger

Info

Publication number
DK0462194T3
DK0462194T3 DK90904852.2T DK90904852T DK0462194T3 DK 0462194 T3 DK0462194 T3 DK 0462194T3 DK 90904852 T DK90904852 T DK 90904852T DK 0462194 T3 DK0462194 T3 DK 0462194T3
Authority
DK
Denmark
Prior art keywords
fgf
growth factor
fibroblast growth
stabilized compositions
tissular
Prior art date
Application number
DK90904852.2T
Other languages
English (en)
Inventor
Denis Barritault
Jacqueline Jozefonvicz
Faouzi Slaoui
Michele Tardieu
Jean-Pierre Caruelle
Jose Courty
Original Assignee
Therapeutiques Substitutives
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9379523&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0462194(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Therapeutiques Substitutives filed Critical Therapeutiques Substitutives
Application granted granted Critical
Publication of DK0462194T3 publication Critical patent/DK0462194T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK90904852.2T 1989-03-09 1990-03-09 Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger DK0462194T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903086A FR2644066B1 (fr) 1989-03-09 1989-03-09 Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques

Publications (1)

Publication Number Publication Date
DK0462194T3 true DK0462194T3 (da) 1994-09-19

Family

ID=9379523

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90904852.2T DK0462194T3 (da) 1989-03-09 1990-03-09 Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger

Country Status (10)

Country Link
EP (1) EP0462194B1 (da)
JP (1) JP3236916B2 (da)
AT (1) ATE106743T1 (da)
AU (1) AU5283890A (da)
CA (1) CA2048638C (da)
DE (1) DE69009748T2 (da)
DK (1) DK0462194T3 (da)
ES (1) ES2057544T3 (da)
FR (1) FR2644066B1 (da)
WO (1) WO1990010456A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202311A (en) * 1988-08-19 1993-04-13 Children's Medical Center Corporation Stabilized fgf composition
US5482929A (en) * 1991-12-26 1996-01-09 Kaken Pharmaceutical Co., Ltd. Composition of stabilized fibroblast growth factor
FR2718026B1 (fr) * 1994-03-30 1997-01-17 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement des muscles.
FR2718024B1 (fr) * 1994-03-30 1996-06-21 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement de l'inflammation.
FR2718025B1 (fr) * 1994-03-30 1996-06-21 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement des lésions du système nerveux.
FR2718023B1 (fr) * 1994-03-30 1996-08-14 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement de lésions du tractus digestif.
FR2772382B1 (fr) * 1997-12-11 2000-03-03 Solutions Derives de dextrane, leur procede de preparation et leurs applications comme medicaments a action biologique specifique
FR2781375A1 (fr) * 1998-07-21 2000-01-28 Denis Barritault Composition anti-fibrotique contenant des polymeres ou biopolymeres et leurs utilisations
FR2781485B1 (fr) 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
ATE363292T1 (de) 1998-09-04 2007-06-15 Scios Inc Hydrogelzusammensetzungen mit kontrollierter freigabe von wachstumsfaktoren
FR2794649B1 (fr) * 1999-06-11 2003-04-11 Solutions Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
FR2794976B1 (fr) * 1999-06-16 2004-05-07 Solutions Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
HUE044239T2 (hu) 2008-03-27 2019-10-28 Purdue Research Foundation Kollagén-kötõ szintetikus peptidoglikánok, elõállításuk és alkalmazási eljárásaik
JP6069307B2 (ja) 2011-05-24 2017-02-01 シミック・アイピー・リミテッド・ライアビリティー・カンパニーＳｙｍｉｃ Ｉｐ， Ｌｌｃ ヒアルロン酸結合合成ペプチドグリカン、その製造および使用方法
US9200039B2 (en) 2013-03-15 2015-12-01 Symic Ip, Llc Extracellular matrix-binding synthetic peptidoglycans
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
US10792106B2 (en) 2016-10-28 2020-10-06 Covidien Lp System for calibrating an electromagnetic navigation system
US11529424B2 (en) 2017-07-07 2022-12-20 Symic Holdings, Inc. Synthetic bioconjugates
US11596399B2 (en) 2021-06-23 2023-03-07 Covidien Lp Anvil buttress attachment for surgical stapling apparatus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ235556A (en) * 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf

Also Published As

Publication number Publication date
ATE106743T1 (de) 1994-06-15
JP3236916B2 (ja) 2001-12-10
CA2048638C (en) 2002-06-11
WO1990010456A1 (fr) 1990-09-20
DE69009748D1 (de) 1994-07-14
FR2644066A1 (fr) 1990-09-14
CA2048638A1 (en) 1990-09-10
ES2057544T3 (es) 1994-10-16
DE69009748T2 (de) 1994-09-22
AU5283890A (en) 1990-10-09
EP0462194A1 (fr) 1991-12-27
EP0462194B1 (fr) 1994-06-08
FR2644066B1 (fr) 1994-05-13
JPH04505756A (ja) 1992-10-08

Similar Documents

Publication Publication Date Title
DK0462194T3 (da) Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger
DE3874813D1 (de) Zusammensetzung zur behandlung der haut.
IL77096A (en) Pharmaceutical compositions for enhancing wound healing comprising angiogene and growth factors
ATE469654T1 (de) Verwendung des erythropoietins zur regeneration von lebergewebe
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
PT1019040E (pt) Inibicao da actividade de p38-quinase por meio de arilureias
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
DE69535976D1 (de) Heilung von Wunden oder fibrotischen Krankheiten unter Verwendung von wenigstens einem Agens gegen einen Wachstumsfaktor
ATE96329T1 (de) Topisch anwendbare pharmazeutische zubereitung.
DE69033970D1 (de) Huperzin a analoge verbindungen
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
DE60035133D1 (de) Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
ATE159171T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
DE69814691D1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
ES2149347T3 (es) Composiciones farmaceuticas de verotoxinas y tratamientos medicos con las mismas.
TR199802706T2 (xx) Bir bitki hastal���n�n iyile�tirilmesi i�in y�ntem.
ES2191825T3 (es) Sales metalicas de acidos biliares con accion fisiologica y su uso en terapia.
ATE127839T1 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
DE69008282D1 (de) Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen.
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь